Lupin Pharmaceuticals Inc. Recall: Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx
Lupin Pharmaceuticals Inc. Recall: Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Lupin Pharmaceuticals Inc.; Product: Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc. Bal
| Recalling firm | Lupin Pharmaceuticals Inc. |
|---|---|
| Product | Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 UNited States. Manufactured by: Lupin Limited, Pithampur, (M.P.) 454 775 India NDC# 68180-316-06 |
| Reason for recall | Out of specification result observed in a dissolution test at the 9-month long term stability time point. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Distributed Nationwide in the USA. |
| Recall initiated | 20211008 |
| Recall number | D-0027-2022 |
| Category | drug |
| State | MD |
| Country | United States |
$29/mo
Try RecallGuard →